Cyclin L1 anticorps
-
- Antigène Voir toutes Cyclin L1 (CCNL1) Anticorps
- Cyclin L1 (CCNL1)
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Cyclin L1 est non-conjugé
-
Application
- Western Blotting (WB)
- Réactivité croisée
- Humain
- Purification
- Purified by antigen-affinity chromatography.
- Immunogène
- Recombinant protein encompassing a sequence within the center region of human Cyclin L1. The exact sequence is proprietary.
- Isotype
- IgG
- Top Product
- Discover our top product CCNL1 Anticorps primaire
-
-
- Indications d'application
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Commentaires
-
Positive Control: 293T , 293T nuclear extract
Validation: Orthogonal
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.12 mg/mL
- Buffer
- 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Antigène
- Cyclin L1 (CCNL1)
- Autre désignation
- cyclin L1 (CCNL1 Produits)
- Sujet
- Cyclin L1 , ANIA6A , BM-001 , PRO1073 , ania-6a,Transcriptional regulator which participates in regulating the pre-mRNA splicing process. Seems to be involved in the regulation of RNA polymerase II (pol II). Functions in association with cyclin-dependent kinases (CDKs) and has a role in the second step of splicing. May be a candidate proto-oncogene in head and neck squamous cell carcinomas (HNSCC). Inhibited by the CDK-specific inhibitor p21.
- Poids moléculaire
- 60 kDa
- ID gène
- 57018
- UniProt
- Q9UK58
-